Hualin Chen

1095 Jiefang Avenue
Wuhan, 430030, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

SAPCD2 Drives Bladder Cancer Progression by Stabilizing TANK and Engaging a CREB-PLAGL2 Feedback Loop to Sustain MAPK Signaling.

SAPCD2 Drives Bladder Cancer Progression by Stabilizing TANK and Engaging a CREB-PLAGL2 Feedback Loop to Sustain MAPK Signaling.

Journal: Cancers

Published: January 02, 2026

The ISG15 axis: a central mediator and therapeutic target in vascular inflammaging.

The ISG15 axis: a central mediator and therapeutic target in vascular inflammaging.

Journal: The journals of gerontology. Series A, Biological sciences and medical sciences

Published: November 14, 2025

Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer.

Malevolent alliance of MYBL2hi cancer stem cell and SPP1+ macrophage confers resistance to neoadjuvant immunotherapy in bladder cancer.

Journal: Journal for immunotherapy of cancer

Published: June 16, 2025

FAM174B remodels the tumor microenvironment, inhibits the infiltration of macrophage, predicts the molecular subtype and therapeutic response of bladder cancer.

FAM174B remodels the tumor microenvironment, inhibits the infiltration of macrophage, predicts the molecular subtype and therapeutic response of bladder cancer.

Journal: International journal of medical sciences

Published: January 08, 2025

Comprehensive pan-cancer single-cell analysis reveals glycolysis-related signatures as predictive biomarkers for immunotherapy response and their role in bladder cancer.

Comprehensive pan-cancer single-cell analysis reveals glycolysis-related signatures as predictive biomarkers for immunotherapy response and their role in bladder cancer.

Journal: International immunopharmacology

Published: December 03, 2024

Machine Learning Models Decoding the Association Between Urinary Stone Diseases and Metabolic Urinary Profiles.

Machine Learning Models Decoding the Association Between Urinary Stone Diseases and Metabolic Urinary Profiles.

Journal: Metabolites

Published: August 22, 2024

Knowledge mapping of exosomes in prostate cancer from 2003 to 2022: a bibliometric analysis.

Knowledge mapping of exosomes in prostate cancer from 2003 to 2022: a bibliometric analysis.

Journal: Discover oncology

Published: May 17, 2024

The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma.

The oncogene MYBL2 promotes the malignant phenotype and suppresses apoptosis through hedgehog signaling pathway in clear cell renal cell carcinoma.

Journal: Heliyon

Published: October 27, 2023

SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway.

SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway.

Journal: iScience

Published: May 08, 2023

Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment.

Machine-learning based integrating bulk and single-cell RNA sequencing reveals the SLC38A5-CCL5 signaling as a promising target for clear cell renal cell carcinoma treatment.

Journal: Translational oncology

Published: April 18, 2023

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients.

Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients.

Journal: Frontiers in immunology

Published: April 02, 2023

PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.

PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling.

Journal: Cell death & disease

Published: March 16, 2023

Showing 1-12 of 19

Last Updated: 09/26/2026